publicações selecionadas artigo académico Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology. 2024 documento Chitinase 3-like-1 identified in large extracellular vesicles from human macrophages: a promising therapeutic drug target for pancreatic cancer (Best Poster Award in the session I of EVs in Cancer) 2023 Darifenacin as novel chemosensitizer in pancreatic cancer 2023